Vivos Inc. (OTCMKTS:RDGL - Get Free Report) was the recipient of a large decline in short interest during the month of December. As of December 31st, there was short interest totalling 25,300 shares, a decline of 61.0% from the December 15th total of 64,900 shares. Based on an average daily volume of 3,461,200 shares, the days-to-cover ratio is presently 0.0 days.
Vivos Trading Down 7.8 %
OTCMKTS RDGL traded down $0.01 on Monday, hitting $0.12. 890,302 shares of the company were exchanged, compared to its average volume of 1,999,700. Vivos has a 1-year low of $0.05 and a 1-year high of $0.26. The firm has a 50 day moving average of $0.10 and a two-hundred day moving average of $0.13. The company has a market cap of $54.86 million, a P/E ratio of -12.49 and a beta of 0.91.
About Vivos
(
Get Free Report)
Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.
See Also
Before you consider Vivos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vivos wasn't on the list.
While Vivos currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
